Divergent functions of NLRP3 inflammasomes in cancer: a review

A Shadab, M Mahjoor, M Abbasi-Kolli… - Cell Communication and …, 2023 - Springer
The cancer is a serious health problem, which is The cancer death rate (cancer mortality) is
158.3 per 100,000 men and women per year (based on 2013–2017 deaths). Both clinical …

Epigenetic underpinnings of inflammation: a key to unlock the tumor microenvironment in glioblastoma

N Chen, C Peng, D Li - Frontiers in Immunology, 2022 - frontiersin.org
Glioblastoma (GBM) is the most common malignant brain tumor in adults, and
immunotherapies and genetic therapies for GBM have evolved dramatically over the past …

Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies

MS Alam, A Sultana, MS Reza, M Amanullah, SR Kabir… - PloS one, 2022 - journals.plos.org
Integrated bioinformatics and statistical approaches are now playing the vital role in
identifying potential molecular biomarkers more accurately in presence of huge number of …

NLRP3 inflammasome in digestive diseases: from mechanism to therapy

R Qiang, Y Li, X Dai, W Lv - Frontiers in Immunology, 2022 - frontiersin.org
Digestive system diseases remain a formidable challenge to human health. NOD-like
receptor family pyrin domain containing 3 (NLRP3) inflammasome is the most characteristic …

Doxycycline attenuates cancer cell growth by suppressing NLRP3-mediated inflammation

M Alsaadi, G Tezcan, EE Garanina, S Hamza… - Pharmaceuticals, 2021 - mdpi.com
NLR family pyrin domain containing 3 (NLRP3) inflammasome formation is triggered by the
damaged mitochondria releasing reactive oxygen species. Doxycycline was shown to …

Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches

F Liu, J Chen, K Li, H Li, Y Zhu, Y Zhai, B Lu, Y Fan… - Molecular Cancer, 2024 - Springer
Ubiquitination, a pivotal posttranslational modification of proteins, plays a fundamental role
in regulating protein stability. The dysregulation of ubiquitinating and deubiquitinating …

Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer

S Hamza, EE Garanina, L Shkair, M Alsaadi… - Pharmaceuticals, 2024 - mdpi.com
The NLR family pyrin domain containing 3 (NLRP3) promotes the growth of colorectal
cancer (CRC). However, the therapeutic effect of NLRP3 inhibition on CRC cell progression …

Picroside II alleviates DSS-induced ulcerative colitis by suppressing the production of NLRP3 inflammasomes through NF-κB signaling pathway

H Yao, J Yan, L Yin, W Chen - Immunopharmacology and …, 2022 - Taylor & Francis
Context Ulcerative colitis (UC) is a common acute or chronic intestinal disease with an
imbalance of inflammation. Picroside II (P-II) exerts a protective role in various inflammation …

[HTML][HTML] Decoding mitochondria's role in immunity and cancer therapy

Y Zhang, H Yan, Y Wei, X Wei - … et Biophysica Acta (BBA)-Reviews on …, 2024 - Elsevier
The functions of mitochondria, including energy production and biomolecule synthesis, have
been known for a long time. Given the rising incidence of cancer, the role of mitochondria in …

Ulinastatin ameliorates the malignant progression of prostate cancer cells by blocking the RhoA/ROCK/NLRP3 pathway

Z Liu, X Zhu, C Xu, F Min, G Yu… - Drug Development …, 2023 - Wiley Online Library
Prostate cancer is a male malignant tumor disease with high incidence and mortality. This
study was designed to explore the effects of ulinastatin (UTI) on the malignant progression of …